CA Patent

CA2669104A1 — Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity

Assigned to UVA Licensing and Ventures Group · Expires 2008-05-29 · 18y expired

What this patent protects

Hydrindane analogs of formula (IA) and (IB) that have agonist activity at one or more of the SlP receptors are provided. The ' compounds are sphingosine analogs, which, after phosphorylation, can behave as agonists at SlP receptors.

USPTO Abstract

Hydrindane analogs of formula (IA) and (IB) that have agonist activity at one or more of the SlP receptors are provided. The ' compounds are sphingosine analogs, which, after phosphorylation, can behave as agonists at SlP receptors.

Drugs covered by this patent

Patent Metadata

Patent number
CA2669104A1
Jurisdiction
CA
Classification
—
Expires
2008-05-29
Drug substance claim
No
Drug product claim
No
Assignee
UVA Licensing and Ventures Group
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.